Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab

Bevacizumab is a humanized monoclonal antibody against vascular endothelial growth factor (VEGF) that has efficacy in recurrent malignant gliomas, particularly in combination with irinotecan. However, responses are rarely durable. Continuation of bevacizumab in combination with another chemotherapeu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Quant, Eudocia C., Norden, Andrew D., Drappatz, Jan, Muzikansky, Alona, Doherty, Lisa, LaFrankie, Debra, Ciampa, Abigail, Kesari, Santosh, Wen, Patrick Y.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Duke University Press 2009
Onderwerpen:
Clinical Investigations
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765344/
https://ncbi.nlm.nih.gov/pubmed/19332770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2009-006
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items